Breaking News: Nimesil with Active Substance Nimesulide Recalled

Recall Details

Nimesil, a non-steroidal anti-inflammatory drug (NSAID) containing nimesulide as an active ingredient, is being recalled due to potential liver damage risk.

The recall affects all batches of Nimesil manufactured by Medinfuchs.de, a German pharmaceutical company. The drug is used to treat pain, inflammation, and fever.

Medinfuchs.de has issued a statement advising patients to stop taking Nimesil immediately and to consult their doctor for alternative treatment options. The company is working with regulatory authorities to investigate the potential health risks associated with the drug.

Patients who have taken Nimesil and are experiencing symptoms such as fatigue, nausea, vomiting, or abdominal pain are urged to seek medical attention promptly.

Further updates on the Nimesil recall will be provided as they become available.